Chemotherapy-Induced Peripheral Neuropathy

View All

Chemotherapy Induced Peripheral Neuropathy
Chemotherapy-Induced Peripheral Neuropathy Market Trends

The recent acquisition of Relief Therapeutics by Sonnet BioTherapeutics will surely fuel the growth of Chemotherapy-Induced Peripheral Neuropathy (CIPN) therapy market. Sonnet plans to commence the development of its promising candidate SON-080 for CIPN treatment. Peripheral Neuropathy is a set of complications cau...

Find More